Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net loss	$ (4,897)	$ (3,549)	$ (14,399)	$ (12,611)
Available for sale securities - net unrealized income (loss)	2	30	34	(1)
Total other comprehensive income (loss)	2	30	34	(1)
Comprehensive loss	(4,895)	(3,519)	(14,365)	(12,612)
Comprehensive income (loss) attributable to noncontrolling interests	1	1	6	(2)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders	$ (4,896)	$ (3,520)	$ (14,371)	$ (12,610)